MTHFR C677T polymorphism and pancreatic cancer risk: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 8, 2012, Pages 3763-3766

  Liu, Xiang Ming ^a   Liu, Feng Hua ^a   Tang, Yong ^a   Li, Qiang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Genetic polymorphism; Meta analysis; Methylenetetrahydrofolate reductase; Pancreatic cancer

Indexed keywords

EID: 84873636725     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.3763     Document Type: Article

References (26)

1. Chiou WK, Huang BY, Chou WY, et al (2011). Incidences of cancers in diabetic and non-diabetic hospitalized adult patients in Taiwan. Asian Pac J Cancer Prev, 12, 1577-81.
2. Cochran WG (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29.
3. Crider KS, Yang TP, Berry RJ, et al (2012). Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr, 3, 21-38.
4. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
5. Dong LM, Potter JD, White E, et al (2008). Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA, 299, 2423-36.
6. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
7. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
8. Goyette P, Sumner JS, Milos R, et al (1994). Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet, 7, 195-200.
9. Goyette P, Pai A, Milos R, et al (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mammalian Genome, 9, 652-6.
10. Hidalgo M (2010). Pancreatic cancer. N Engl J Med, 362, 1605-17.
11. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
12. Kouidhi S, Rouissi K, Khedhiri S, et al (2011). MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage. Asian Pac J Cancer Prev, 12, 2227-32.
13. Li D, Ahmed M, Li Y, et al (2005). 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 14, 1470-6.
14. Lin D, Li H, Tan W, et al (2007). Genetic polymorphisms in folate- metabolizing enzymes and risk of gastroesophageal cancers: a potential nutrient-gene interaction in cancer development. Forum Nutr, 60, 140-5.
15. Liu YX, Wang B, Wan MH, et al (2011). Meta-analysis of the relationship between the metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac J Cancer Prev, 12, 247-52.
16. Lin Y, Yagyu K, Egawa N, et al (2011). An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies. J Epidemiol, 21, 2-12.
17. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
18. Matsubayashi H, Skinner HG, Iacobuzio-Donahue C, et al (2005). Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes. Clin Gastroenterol Hepatol, 3, 752-60.
19. Milne RL, Greenhalf W, Murta-Nascimento C, et al (2009). The inherited genetic component of sporadic pancreatic adenocarcinoma. Pancreatology, 9, 206-14.
20. Nisevic I, Dinic J, Nikolic A, et al (2008). MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma. Cell Biochem Funct, 26, 659-63.
21. Raimondi S, Maisonneuve P, Lowenfels AB (2009). Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol, 6, 699-708.
22. Suzuki T, Matsuo K, Sawaki A, et al (2008). Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev, 17, 2742-7.
23. Taghavi A, Fazeli Z, Vahedi M, et al (2011). Pancreatic cancer mortality and misclassification-bayesian analysis. Asian Pac J Cancer Prev, 12, 2271-4.
24. Wang L, Lin DX, Lu XH, et al (2006). Study on the relations between genetic polymorphisms in methylenetetrahydrofolate reductase, methionine synthase and the risk of pancreatic cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 27, 50-4 (in Chinese).
25. Wang L, Miao X, Tan W, et al (2005). Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin Gastroenterol Hepatol, 3, 743-51.
26. Yang XO, Qian JM (2009). The study of the releVant SNPs on the risk of pancreatic cancer and high risk population. Chinese Post-Graduate Dissertations, Peking Union Medical College.